Axsome Therapeutics Inc. | Key People and Executives
Herriott Tabuteau
Chairman & Chief Executive Officer
Myrtle S. Potter
Independent Director
Roger A. Jeffs
Lead Independent Director
Mark E. Saad
Independent Director
Mark Coleman
Independent Director
Herriott Tabuteau
Chairman & Chief Executive Officer
Mark L. Jacobson
Secretary & Vice President-Operations
Nick Pizzie
Chief Financial Officer
Cedric O'Gorman
SVP-Clinical Development & Medical Affairs
Myrtle S. Potter
Independent Director
Roger A. Jeffs
Lead Independent Director
Mark E. Saad
Independent Director
Mark Coleman
Independent Director
| Address |
200 Broadway
New York New York 10038
United States
|
|
Employees
|
- |
| Website |
http://www.axsome.com |
| Updated |
07/08/2019 |
| Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY. |
